Review Article
The Role of Mesenchymal Stem Cell Secretome (Extracellular Microvesicles and Exosomes) in Animals’ Musculoskeletal and Neurologic-Related Disorders
Table 1
Action of mesenchymal stem cells’ extracellular vesicles (EV) through miRNA’s expression and production on bone formation.
| EV’s action | miRNA | miRNA’s action | Reference |
| Reduce expression | miRNA-144, miRNA-31, and miRNA-221 | Inhibitors of osteogenesis | [46] | Increase expression | miRNA-21 | Improvement in bone production | [46] | Increase expression | miRNA-146a-5p, miRNA-503-5p, miRNA-483-3p, and miRNA-129-5p | Related positively to new bone formation | [47] | Inhibition of action | miRNA-32-5p, miRNA-133-3p, and miRNA-204-5p | Activation of PI3K/AKT and MAP-kinase pathway, reducing osteogenesis | [47] | Production and secretion | miRNA-375 | Activation of the IGFBP3 gene, responsible for increasing osteoblast proliferation | [45] | Production and secretion | miRNA-148-a | WNT5A/Ror2 pathway, reducing adipogenic differentiation, and increasing osteogenic potential | [48] | Production and secretion | miRNA-877 | Increased expression of BMP2, which increases angiogenesis and bone deposition | [49] | Overexpression | miRNA-126 | Induces osteoregeneration and VEGF’s expression | [50] | [51] |
|
|